Sylogist Ltd.
SYZLF
$6.32
-$0.1899-2.92%
| Weiss Ratings | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C | |||
| Rating Factors | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.67 | |||
| Price History | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.37% | |||
| 30-Day Total Return | -6.00% | |||
| 60-Day Total Return | -11.01% | |||
| 90-Day Total Return | -19.23% | |||
| Year to Date Total Return | 3.79% | |||
| 1-Year Total Return | -1.09% | |||
| 2-Year Total Return | 51.73% | |||
| 3-Year Total Return | -14.49% | |||
| 5-Year Total Return | 5.43% | |||
| 52-Week High % Change | -25.60% | |||
| 52-Week Low % Change | 11.74% | |||
| Price | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.75 | |||
| 52-Week Low Price | $5.83 | |||
| 52-Week Low Price (Date) | Jan 13, 2025 | |||
| 52-Week High Price (Date) | Aug 26, 2024 | |||
| Valuation | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 151.07M | |||
| Enterprise Value | 155.17M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | 1,123.53% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.13 | |||
| Price/Book (Q) | 5.85 | |||
| Enterprise Value/Revenue (TTM) | 3.18 | |||
| Price | $6.32 | |||
| Enterprise Value/EBITDA (TTM) | 14.43 | |||
| Enterprise Value/EBIT | 51.02 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 23.48M | |||
| Dividend Yield | 0.44% | |||
| Div. Per Share (Most Recent) | $0.01 | |||
| Dividend Per Share (TTM) | $0.03 | |||
| Payout Ratio (TTM) | -75.65% | |||
| Dividend Per Share (Most Recent) | $0.01 | |||
| Company Info | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 403 266 4808 | |||
| Address | 5 Richard Way SW Calgary, AB T3E 7M8 | |||
| Website | www.sylogist.com | |||
| Country | Canada | |||
| Year Founded | 1993 | |||
| Profitability | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 6.22% | |||
| Profit Margin | -1.86% | |||
| Management Effectiveness | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.56% | |||
| Return on Equity | -- | |||
| Income Statement | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 47.79M | |||
| Total Revenue (TTM) | 48.84M | |||
| Revenue Per Share | $2.08 | |||
| Gross Profit (TTM) | 28.78M | |||
| EBITDA (TTM) | 10.76M | |||
| EBIT (TTM) | 3.04M | |||
| Net Income (TTM) | -911.60K | |||
| Net Income Avl. to Common (TTM) | -911.60K | |||
| Total Revenue Growth (Q YOY) | -2.86% | |||
| Earnings Growth (Q YOY) | -172.03% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | -182.40% | |||
| Balance Sheet | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.86M | |||
| Cash Per Share (Q) | $0.42 | |||
| Total Current Assets (Q) | 22.05M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 26.03M | |||
| Current Ratio (Q) | 0.543 | |||
| Book Value Per Share (Q) | $1.11 | |||
| Total Assets (Q) | 73.29M | |||
| Total Current Liabilities (Q) | 40.58M | |||
| Total Debt (Q) | 14.25M | |||
| Total Liabilities (Q) | 47.25M | |||
| Total Common Equity (Q) | 26.03M | |||
| Cash Flow | SYZLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -6.85M | |||
| Cash from Financing (TTM) | -3.02M | |||
| Net Change in Cash (TTM) | -338.30K | |||
| Levered Free Cash Flow (TTM) | 7.20M | |||
| Cash from Operations (TTM) | 9.55M | |||
